Dyne Therapeutics, Inc.
DYN
$13.51
$0.9257.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -70.28% | -75.72% | -34.37% | -61.31% | -0.31% |
| Total Depreciation and Amortization | 26.07% | 30.05% | 12.78% | 1.62% | -7.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 79.02% | -35.73% | 72.55% | 68.46% | 20.78% |
| Change in Net Operating Assets | 32.95% | 89.03% | -119.92% | 215.09% | 1.05% |
| Cash from Operations | -72.60% | -34.83% | -140.92% | -47.48% | 1.39% |
| Capital Expenditure | 93.00% | -413.61% | -1,210.98% | -51.50% | -242.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.20% | 101.36% | -156.83% | -247.44% | -31.18% |
| Cash from Investing | -39.38% | 100.81% | -161.12% | -251.34% | -35.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.48% | -65.41% | 2,373.47% | 3,866.74% | 1,425.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -73.47% | -65.41% | 2,373.47% | 3,866.74% | 1,425.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.18% | -75.46% | -1,016.35% | -103.67% | 2,589.40% |